tradingkey.logo

Mangoceuticals Inc

MGRX
1.800USD
0.000
Cierre 11/05, 16:00ETCotizaciones retrasadas 15 min
19.16MCap. mercado
PérdidaP/E TTM

Más Datos de Mangoceuticals Inc Compañía

Mangoceuticals, Inc. is primarily focused on developing, marketing, and selling a variety of men’s health and wellness products and services via a secure telemedicine platform. The Company has developed and is commercially marketing a new brand of erectile dysfunction (ED) products under the brand name Mango and a brand of hair loss products under the brand name Grow. These products are produced at a compounding pharmacy using a proprietary combination of United States Food and Drug Administration (FDA) approved ingredients and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. It is marketing and selling these branded ED and hair loss products exclusively online via its Website at www.MangoRx.com. Its customer platform connects consumers to licensed healthcare professionals through its Website for the provision of care via telehealth. It also owns a global patent portfolio of oral solution.

Información de Mangoceuticals Inc

Símbolo de cotizaciónMGRX
Nombre de la empresaMangoceuticals Inc
Fecha de salida a bolsaMar 21, 2023
Director ejecutivoMr. Jacob D. Cohen
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 21
Dirección15110 Dallas Pkwy, Suite 600
CiudadDALLAS
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal75248
Teléfono18336264679
Sitio Webhttps://www.mangorx.com/
Símbolo de cotizaciónMGRX
Fecha de salida a bolsaMar 21, 2023
Director ejecutivoMr. Jacob D. Cohen

Ejecutivos de Mangoceuticals Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Eugene M. Johnston
Mr. Eugene M. Johnston
Chief Financial Officer
Chief Financial Officer
138.33K
+260.87%
Dr. Kenny Myers
Dr. Kenny Myers
Independent Non-Executive Director
Independent Non-Executive Director
136.67K
+272.72%
Mr. Alex P. Hamilton
Mr. Alex P. Hamilton
Independent Non-Executive Director
Independent Non-Executive Director
126.67K
+375.00%
Mr. Jacob D. Cohen
Mr. Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lorraine Dalessio, Esq.
Ms. Lorraine Dalessio, Esq.
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Eugene M. Johnston
Mr. Eugene M. Johnston
Chief Financial Officer
Chief Financial Officer
138.33K
+260.87%
Dr. Kenny Myers
Dr. Kenny Myers
Independent Non-Executive Director
Independent Non-Executive Director
136.67K
+272.72%
Mr. Alex P. Hamilton
Mr. Alex P. Hamilton
Independent Non-Executive Director
Independent Non-Executive Director
126.67K
+375.00%
Mr. Jacob D. Cohen
Mr. Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lorraine Dalessio, Esq.
Ms. Lorraine Dalessio, Esq.
Independent Non-Executive Director
Independent Non-Executive Director
--
--

Desglose de ingresos

Sin datos
Sin datos
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: sáb., 6 de sep
Actualizado: sáb., 6 de sep
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Cohen (Jacob D.)
9.56%
Navy Wharf, Ltd.
7.32%
Propre Energie Inc
4.76%
Greenfield Investments Ltd
3.77%
The Vanguard Group, Inc.
1.34%
Otro
73.25%
Accionistas
Accionistas
Proporción
Cohen (Jacob D.)
9.56%
Navy Wharf, Ltd.
7.32%
Propre Energie Inc
4.76%
Greenfield Investments Ltd
3.77%
The Vanguard Group, Inc.
1.34%
Otro
73.25%
Tipos de accionistas
Accionistas
Proporción
Corporation
15.85%
Individual Investor
14.02%
Investment Advisor
1.63%
Hedge Fund
0.24%
Investment Advisor/Hedge Fund
0.19%
Research Firm
0.08%
Otro
67.98%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
27
292.25K
2.14%
+144.27K
2025Q2
38
3.44M
29.63%
+1.40M
2025Q1
35
1.92M
37.79%
+1.11M
2024Q4
34
1.29M
45.58%
-18.06K
2024Q3
32
811.21K
40.72%
-490.52K
2024Q2
27
759.36K
45.89%
-544.02K
2024Q1
26
674.02K
59.33%
-527.17K
2023Q4
22
660.62K
58.15%
-532.64K
2023Q3
19
652.27K
63.81%
+112.43K
2023Q2
12
649.40K
63.58%
+115.75K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Cohen (Jacob D.)
1.30M
12.39%
+500.00K
+62.11%
Jul 21, 2025
Navy Wharf, Ltd.
1.00M
9.49%
+1.00M
--
May 27, 2025
Propre Energie Inc
650.00K
6.17%
--
--
May 27, 2025
Greenfield Investments Ltd
515.00K
4.89%
--
--
May 27, 2025
The Vanguard Group, Inc.
182.61K
1.73%
+182.61K
--
Jun 30, 2025
Johnston (Eugene M)
138.33K
1.31%
+100.00K
+260.87%
Sep 09, 2025
Myers (Kenny)
136.67K
1.3%
+100.00K
+272.72%
Sep 09, 2025
D'Alessio (Lorraine Pamela)
136.67K
1.3%
+100.00K
+272.72%
Sep 09, 2025
Hamilton (Alex P)
126.67K
1.2%
+100.00K
+375.00%
Sep 09, 2025
Isaac (Antonios)
60.00K
0.57%
--
--
May 27, 2025
Ver más

ETFs relacionados

Nombre
Proporción
Sin datos

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Fecha
Tipo
Relación
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
KeyAI